Core Viewpoint - Catheter Precision, Inc. is participating in the 13th International Symposium on Left Atrial Appendage (ISLAA) to showcase its innovative medical device, LockeT, which aids in wound closure after cardiac procedures [1][2][4]. Company Overview - Catheter Precision is a U.S.-based medical device company focused on developing advanced solutions for cardiac arrhythmias and electrophysiology procedures [5]. - The company collaborates with physicians to continuously advance its product offerings [5]. Event Participation - The ISLAA meeting is a multi-specialty cardiovascular educational symposium featuring leading physicians and institutions [2]. - Catheter Precision will engage in hands-on demonstrations and product education for electrophysiology fellows, allowing them to experience LockeT and understand its benefits [3]. Product Information - LockeT is a Class 1 FDA-registered suture retention device designed to assist in wound closure after percutaneous venous punctures [4]. - The device addresses challenges associated with closing large access sites after left atrial appendage procedures, providing a safe and effective solution [4].
Catheter Precision to Attend and Participate in the 13th Internation Symposium on Left Atrial Appendage